A bidimensional early intervention strategy of standard of care in combination with corticosteroids in elderly patients with mild to moderate COVID-19 (BEAT-COV study): a multicentre, open-label, randomized controlled trial.

Although the difference did not reach statistical significance ( p = 0.3688), these findings provide preliminary evidence supporting the potential clinical value of corticosteroid in this high-risk subgroup, and further verification of their definitive efficacy is warranted in large-scale randomized controlled trials.

also in 111,027 other papers

In this high-risk subgroup, the corticosteroid group showed a trend toward reduced the risk of severe disease (RR = 0.26, 95%CI 0.03–2.29).

also in 53,322 other papers